top of page

Topic

Breast Oncology

4 Podcasts on BackTable

Hear how experienced clinicians in Breast Oncology approach day-to-day decision-making on BackTable. Learn from podcasts, cases, and courses curated by physician content creators. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Breast Cancer Precision Medicine: Biomarkers & Treatments
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Tumor Board

Episode # 56  •  21 Apr 2026

Breast Cancer Precision Medicine: Biomarkers & Treatments

Here’s a practical guide on how biomarkers can guide treatment and cut costs for your breast cancer patients. In this episode of the BackTable Tumor Board Podcast, Dr. Lindsay Peterson and Dr. Jessica Trevino Jones review the role of precision medicine and biomarkers in early-stage and metastatic disease, specifically in breast cancer.

More on Breast Oncology

Loading recent podcasts…

Tumor Board

Tumor Board Episode #56

Apr 21, 2026

with Dr. Jessica Jones, Dr. Lindsay Peterson

Breast Cancer Precision Medicine: Biomarkers & Treatments

Here’s a practical guide on how biomarkers can guide treatment and cut costs for your breast cancer patients. In this...

170+ listens

Tumor Board

Tumor Board Episode #49

Feb 24, 2026

with Dr. Bora Lim, Dr. Lindsay Peterson

Inflammatory Breast Cancer: Symptoms, Diagnosis & Management

Inflammatory breast cancer (IBC) is rare but highly aggressive, and often hides in plain sight. Rather than presenting...

190+ listens

Tumor Board

Tumor Board Episode #52

Mar 24, 2026

with Dr. Sara Nunnery, Dr. Kate Baker

Antibody Drug Conjugates Across the HER2 Spectrum: From HER2-Positive to Ultralow Breast Cancer

Antibody-drug conjugates (ADCs) are expanding treatment options in breast cancer, but their use requires careful...

170+ listens

Tumor Board

Tumor Board Episode #48

Feb 17, 2026

with Dr. Erika Hamilton, Dr. Lindsay Peterson

HER2-Positive Metastatic Breast Cancer: Treatment Insights & Protocols

In a patient with metastatic HER2-positive breast cancer, what should guide the next decision: trial data, toxicity, or...

260+ listens

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page